INNOVA CAPTAB
Back to Balance Sheet
|
INNOVA CAPTAB Last 5 Year Net Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹343 Cr | ₹314 Cr | ₹165 Cr | ₹85 Cr | ₹55 Cr |
What is the latest Net Current Assets ratio of INNOVA CAPTAB ?
| Year | Net Current Assets |
|---|---|
| Mar2025 | ₹343 Cr |
| Mar2024 | ₹314 Cr |
| Mar2023 | ₹165 Cr |
| Mar2022 | ₹85 Cr |
| Mar2021 | ₹55 Cr |
How is Net Current Assets of INNOVA CAPTAB Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹343 Cr | 9.04 | |
| Mar2024 | ₹314 Cr | 90.56 | |
| Mar2023 | ₹165 Cr | 95.09 | |
| Mar2022 | ₹85 Cr | 52.84 | |
| Mar2021 | ₹55 Cr | - | |
Compare Net Current Assets of peers of INNOVA CAPTAB
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INNOVA CAPTAB | ₹3,825.5 Cr | -1.5% | -3.6% | -13.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹417,028.0 Cr | 0.3% | 9% | 8.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹170,237.0 Cr | 1.9% | 5.9% | 12.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹146,801.0 Cr | 0.6% | 9.5% | 45% | Stock Analytics | |
| CIPLA | ₹108,861.0 Cr | 1.6% | 1.8% | -7.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,435.0 Cr | -1.5% | 5.7% | 14.5% | Stock Analytics | |
INNOVA CAPTAB Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INNOVA CAPTAB | -1.5% |
-3.6% |
-13.7% |
| SENSEX | -1.8% |
-1.6% |
7.3% |
You may also like the below Video Courses